Great to meet you at Interclean 2024
Our Testing Capabilities Relevant to the Cleaning Industry
Surface Cleaner Efficacy Evaluation
- Determination of disinfectant wipe effectiveness in eliminating allergen or micro-organisms (virus, bacteria or mould) from surfaces.
- Assessment of mop cleaning performance for removing/inactivating viruses or bacteria from floors
- Evaluation of vacuum cleaner surface cleaning efficiency in removing allergen or micro-organisms (virus, bacteria or mould) from carpets and upholstery
- Testing of robotic cleaner performance for removing allergen or micro-organisms (virus, bacteria or mould) from various surfaces
Air Cleaning Technology Testing
Efficiency Evaluation in an environmental chamber (AHAM AC-1)
- Assessment of filter efficiency in removing airborne contaminants (viruses, bacteria, mould or allergen).
- Determination of UV light effectiveness in inactivating airborne viruses or bacteria
- Evaluation of electrostatic precipitation performance in capturing airborne contaminants, including virus, bacteria or mould.
- Testing of Bi-Polar Ionisation efficacy in reducing airborne viral or bacterial load
Air Cleaning Technology Testing
Efficiency Assessment of in-duct air cleaning technologies (ASHRAE)
For ASHRAE 241 requirements, the impact of a filter or an air cleaning technology on removing MS2 Bacteriophage from circulating air can be tested in the duct and/or in the adjoining chamber.
Air cleaning technologies that can be assessed include one or a combination of the following components:
- Filters
- UV
- Bi-polar ionisation
- Electrostatic precipitation
Infectious contaminants other than MS2 Bacteriophage include:
- H1N1
- Rhinovirus
- Feline Calicivirus, a norovirus surrogate
Other viruses, bacteria or mould can also be assessed against the above technologies along with airborne particulates, ions, ozone and VOCs.
Emission Testing
- Assessment of bacteria or viral particle dispersion from hand dryers in public restrooms
- Measurement of emissions from air cleaner technologies during operation.
- Emissions may include ozone, VOCs and formaldehyde
(of relevance to ASHRAE 241). - Quantification of bacteria, virus or allergen particle release or redistribution from products during operation
What People Are Saying
Mr. Robert Hickson
MD of Vitra
“The quality of the third party data we received from Airmid helped us showcase our innovative strategy of licensing this novel technology at a prestigious international scientific event, the European Innovation Convention. Ultimately this will allow us add value and differentiate our customer offerings through a focus on health and indoor air quality.”
Rick Robinson
President at Spring Air
“Since 1926, Spring Air has provided innovative mattresses and sleep sets to the US consumer. Our investment in ground-breaking research with our partner airmid healthgroup, will provide new and superior, third-party-validated, healthy sleep products.”
Roger Frye
VP Global Marketing, Fellowes Work Solutions
“Working with airmid healthgroup has given us access to valuable knowledge in aerobiology and indoor air quality… Their scientific expertise and rigorous testing process has supported our message that Fellowes AeraMax™ air purifiers can make a real contribution to improving the quality of air in homes and offices.”
